The exosome diagnostic and therapeutic market in Europe is expected to grow from US$ 12,524.24 thousand in 2019 to US$ 1,04,694.72 thousand by 2027. This represents a CAGR of 31.7% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to greater precision and advantages over traditional methods of diagnosis and therapeutics, rise in research and development activities. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the Europe exosome diagnostic and therapeutic market during the forecast period.
The Germany has observed fast growth in the exosome diagnostic and therapeutic market within the past few years and is expected to lead the market in Europe during the forecast period. Currently, exosomes are rapidly gaining momentum in accessing therapeutic effects of stem cells. For instance, Cancer cases are rising in Germany, stressing on the need for advanced diagnostic tools. As per the Globocan, in 2018, nearly 608,742 cases of cancer were reported in the country. The country has one of the most advanced healthcare facilities and spends a significant amount on healthcare expenditure. Health insurance is mandatory in Germany and offered by two providers, the statutory health insurance (SHI) system and substitutive private health insurance (PHI). The advanced healthcare facilities and demand for less invasive diagnostic tools for cancer screening are driving the growth of the market..
Germany Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (US$ Thousand)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC – MARKET SEGMENTATION
By Application
- Diagnostic
- Therapeutic
By Product
- Instruments
- Reagents
- Software
By End User
- Cancer Institutes
- Hospitals
- Diagnostic Centers
- Others
By Country
- Germany
- France
- UK
- Italy
- Spain
Company Profiles
- Cell Guidance Systems
- Evomic Science LLC
- EXOSOME DIAGNOSTICS
- ITH, Immune Therapy Holdings AB
- Miltenyi Biotec
- Norgen Biotek Corp
- RENEURON GROUP PLC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application, Product, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Exosome diagnostic and therapeutic Market – By Application
1.3.2 Europe Exosome diagnostic and therapeutic Market – By Product
1.3.3 Europe Exosome diagnostic and therapeutic Market – By End User
1.3.4 Europe Exosome Diagnostic and Therapeutic Market – By Country
2. Exosome Diagnostic And Therapeutic Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Exosome Diagnostic and Therapeutic Market – Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 Europe– PEST Analysis
5. Europe Exosome Diagnostic and Therapeutic Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
5.1.2 Rise in Research and Development Activities
5.2 Key Market Restraints
5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
5.3 Key Market Opportunities
5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
5.4 Future Trends
5.4.1 Automation of Exosome Isolation Process
5.5 Impact analysis
6. Exosome Diagnostic and Therapeutic Market Analysis – By Application
6.1 Overview
6.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
6.3 Diagnostic
6.3.1 Overview
6.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
6.4 Therapeutic
6.4.1 Overview
6.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
7. Exosome Diagnostic and Therapeutic Market Analysis By Product
7.1 Overview
7.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
7.5 Software
7.5.1 Overview
7.5.2 Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8. Exosome Diagnostic and Therapeutic Market Analysis By End User
8.1 Overview
8.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
8.3 Cancer Institutes
8.3.1 Overview
8.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.4 Hospitals
8.4.1 Overview
8.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.5 Diagnostic Centres
8.5.1 Overview
8.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.6 Other End User
8.6.1 Overview
8.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
9. Exosome Diagnostic and Therapeutic Market – Country Analysis
9.1 Europe: Exosome Diagnostic and Therapeutic Market
9.1.1 Overview
9.1.2 Europe: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.3 Europe: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)
9.1.4 Europe: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.5 Europe: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.6 Europe: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
9.1.7 Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.7.1 Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.8 Germany: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.9 Germany: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.10 Germany: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.11 France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.11.1 France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.12 France: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.13 France: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.14 France: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.15 UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.15.1 UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.16 UK: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.17 UK: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.18 UK: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.19 Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.19.1 Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.20 Italy: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.21 Italy: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.22 Italy: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.23 Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.23.1 Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.24 Spain: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.25 Spain: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.26 Spain: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
10. IMPACT OF COVID-19 PANDEMIC ON EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET
10.1 Europe: Impact assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 Cell Guidance Systems
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Evomic Science LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Norgen Biotek Corp
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Miltenyi Biotec
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 RENEURON GROUP PLC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 ITH, Immune Therapy Holdings AB
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 EXOSOME DIAGNOSTICS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousands)
Table 2. Europe Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 3. Europe Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 4. Germany Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 5. Germany Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 6. Germany Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 7. France Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 8. France Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 9. France Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 10. UK Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 11. UK Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 12. UK Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 13. Italy Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 14. Italy Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 15. Italy Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 16. Spain Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 17. Spain Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 18. Spain Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 19. Glossary of Terms, Exosome diagnostic and treatment market
LIST OF FIGURES
Figure 1. Exosome Diagnostic and Therapeutic Market Segmentation
Figure 2. Exosome Diagnostic and Therapeutic Segmentation, By Region
Figure 3. Europe Exosome Diagnostic and Therapeutic Market Overview
Figure 4. Diagnostics Held Largest Share Of Application Segment In Exosome diagnostic and Therapeutic Market
Figure 5. Germany Is Expected to Show Remarkable Growth during the Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Exosome diagnostic and therapeutic market impact analysis of driver and restraints
Figure 8. Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
Figure 9. Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 10. Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 11. Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)
Figure 12. Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 13. Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 14. Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 15. Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)
Figure 16. Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 17. Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 18. Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 19. Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 20. Europe: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)
Figure 21. Europe Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)
Figure 22. Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 23. France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 24. UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 25. Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 26. Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 27. IMPACT OF COVID-19 PANDEMIC IN EUROPE COUNTRY MARKETS
- Cell Guidance Systems
- Evomic Science LLC
- Exosome Diagnostics
- ITH, Immune Therapy Holdings AB
- Miltenyi Biotec
- Norgen Biotek Corp
- Reneuron Group Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Exosome Diagnostic and Therapeutic Market
Aug 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)